ORX:STO
Orexo AB
SEK 1.37
arrow_downward
-1.58%(-0.022) 1D
Nov 6, 5:29:49 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 1.47
High
SEK 1.47
Low
SEK 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEK 36.00
52-wk low
SEK 1.30
EPS
SEK 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEK 1.47
High
SEK 1.47
Low
SEK 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEK 36.00
52-wk low
SEK 1.30
EPS
SEK 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
TradingView
·
1 hour ago
S&P 500 Consumer Discretionary Earnings: 89% beat EPS estimates this week
Traders Union
·
1 hour ago
Brad Gerstner: $1,000 invested for each child born in auto-created U.S. Treasury S&P 500 accounts
富途牛牛
·
8 hours ago
JPMorgan: The momentum crash is a mid-cycle correction within the AI supercycle; maintains S&P 500 target at 8,000 points.
Investing.com
·
3 hours ago
Poland’s Domanski blames presidential vetoes as S&P cuts outlook to negative
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com